BridgeBio Pharma (NASDAQ:BBIO) detailed positive Phase 3 results from its PROPEL-3 clinical trial evaluating oral ...
Targeted therapies for transthyretin amyloid cardiomyopathy (ATTR-CM) were associated with significant reductions in all-cause mortality and cardiovascular hospitalizations compared with untreated ...
Find out more about how a ketogenic diet performed in a UK trial for treatment-resistant depression and what it means ...
Women with enlarged breast tissue who experience frequent headaches are often told they have “tension headaches,” but new ...
SANTA MONICA, Calif. and PENSACOLA, Fla., Feb. 12, 2026 /PRNewswire/ -- Physicians from University Foot & Ankle Institute, in ...
PROPEL 3 successfully met the primary endpoint of change from baseline in AHV at Week 52 (p<0.0001)- Change from baseline in AHV was ...
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
Confusion about the safety of taking the drugs during pregnancy has led to mental health emergencies for some expectant ...
The question of whether prehospital emergency anaesthesia and intubation improves survival in patients with major trauma has ...
Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, ...
How an excessive focus on methods has distracted attention from the more fundamental challenge of building rigor and learning ...
Our findings indicate that a large commercial insurer is increasingly covering acupuncture for its beneficiaries. Unlike Medicare Part B, which limits acupuncture coverage to chronic low back pain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results